Viewing Study NCT02094560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-03-12 @ 12:54 AM
Study NCT ID: NCT02094560
Status: TERMINATED
Last Update Posted: 2018-09-05
First Post: 2014-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors
Sponsor: CellAct Pharma GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Endstage Solid Carcinomas in Adults View
Keywords:

Keywords

Keyword Brief Keyword Text View
None therapy refractory View
None endstage View
None solid tumours View